Verastem

VSTM · NASDAQ

$9.34+$0.72 (+8.35%)TodayMarket closed · Oct 20, 7:41 PM ET

Prev close $8.62

About VSTM

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company is headquartered in Needham, Massachusetts and currently employs 102 full-time employees. The company went IPO on 2011-11-08. Its product candidates include avutometinib and defactinib. Avutometinib is an oral RAF/MEK clamp that inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with A-Raf proto-oncogene, potentially serine/threonine kinase (ARAF), B-Raf proto-oncogene serine/threonine kinase (BRAF) and C-raf proto-oncogene serine/threonine kinase, creating antitumor response through maximal RAS/MAPK pathway inhibition. Defactinib is an oral, selective inhibitor of FAK and proline-rich tyrosine kinase (PYK2), the two members of the focal adhesion kinase family of non-receptor protein tyrosine kinases. FAK and PYK2 integrate signals from integrin and growth factor receptors to regulate cell proliferation.

Employees: 102
Headquarters: Needham, Massachusetts
Listed: Nov 8, 2011
Sector: Health Care
Industry: Biotechnology
Website: verastem.com

Leadership

Verastem executives
Name	Title	Since	Age
John Johnson	—	—	67
Daniel Paterson	—	2012	64
Daniel Calkins	—	—	37
Michael Kauffman	—	2012	61
Robert Gagnon	—	2018	51
Brian Stuglik	—	2017	66
Paul Bunn	—	—	80
Anil Kapur	—	—	55
Michelle Robertson	—	—	58
Eric Rowinsky	—	—	68
Julissa Viana	—	2024	—

Revenue by product and region

Fiscal year ended Dec 31, 2021: $2.05M total revenue

By product

Represents information pertaining to Copiktra license and other revenue.$1.45M70.5%
represents the information pertaining to transition services revenue.$606.00K29.5%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Verastem suppliers and customers
Company	Relationship	Country	Correlation
Mirati Therapeutics MRTX	Supplier and customer	US	0.82
CSPC Pharmaceutical Group	Supplier and customer	HK	0.66
Chugai Pharmaceutical	Supplier and customer	JP	0.64
Certara CERT	Supplier	US	0.53
Yakult Honsha	Supplier and customer	JP	-0.24
Sanofi SAN.PA	Supplier and customer	FR	-0.64
Pfizer PFE	Supplier and customer	US	-0.76
Secura Bio, Inc.	Customer	US	—

Similar companies

Companies in the same industry as Verastem

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.